Transitions in Cancer Survivorship Care Conference March 12
The UC Cancer Institute is hosting the 2016 Cancer Survivorship Research and Best Practice Conference, titled "Transitions in Cancer Survivorship Care, from 8 a.m. to 4:30 p.m. Saturday, March 12, at the Kingsgate Marriott Conference Center, 151 Goodman Drive. Catherine Alfano, PhD, vice president of survivorship for the American Cancer Society, will be the keynote speaker. Other speakers include Tara Olive Henderson, MD, University of Chicago; Deborah Mayer, PhD, University of North Carolina-Chapel Hill; Lynne Padgett, PhD, American Cancer Society; and Julie Silver, MD, Harvard Medical School.
Conference speakers will address transitions that occur along the cancer survivorship continuum, the gaps in coordination of care during transitions and strategies to improve and enhance the transition process between and among providers and settings.
The conference is aimed at any health care provider who specializes or has an interest in cancer survivorship. The cost is $120 for physicians, $85 for nurses and allied health professionals and $50 for residents and students.
>> See the full agenda, register and book your accomodations.
With questions, contact Beverly Reigle at 513-558-4472 or reiglebs@uc.edu.
Tags
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.